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Abstract
Soy protein, a rich source of phytoestrogens, exhibit estrogen-type bioactivity. The purpose of this
study was to determine if ingestion of isoflavones before ovariectomy can prevent bone loss
following ovariectomy. Twenty-four nulliparous Wistar rats were randomly divided into four
groups. In the normal diet groups, a sham operation was performed on Group A, while
ovariectomy was performed on Group B. For Groups C and D, all rats were fed with an isoflavone-
rich (25 mg/day) diet for one month, then bilateral ovariectomy were performed. In the rats in
Group C, a normal diet was begun following the ovariectomy. The rats in Groups D continued to
receive the isoflavone-rich diet for two additional months postoperatively. All rats were sacrificed
60 days after surgery. The weight of bone ash of the long bones and whole lumbar spine were
determined. A histological study of cancellous bone was done and biochemical indices of skeletal
metabolism were performed and analyzed. The markers of bone metabolism exhibited no
significant changes. When compared with the sham-operated rats fed a normal diet, the bone mass
of ovariectomized rats decreased significantly; pre-ovariectomy ingestion of an isoflavone-rich diet
did not prevent bone loss. The bone mass of rats treated with an isoflavone-rich diet for three
months was higher than controls two months after ovariectomy.
Dietary isoflavones did not prevent the development of post-ovariectomy bone loss, but long-term
ingestion of an isoflavone-rich diet increased the bone mineral contents after ovariectomy in young
rats.
Introduction
Osteoporosis is a complex disease characterized by a
reduction in bone mass with associated microarchitec-
tural deterioration and a correspondingly high risk of frac-
tures. It is a serious and costly public health problem in
the elderly population [1]. Osteoporotic fractures are an
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important cause of disability. Osteoporosis and the conse-
quences of compromised bone strength, particularly ver-
tebral and hip fractures, is a significant cause of increased
morbidity and even mortality. Hip fractures are associated
with a 20% mortality in the year following the fracture [2].
As driven by the aging of the baby boomers and by the
increasing longevity, the size of the population aged 50
years or older will increase markedly during the next sev-
eral decades. Consequently, the cost of managing frac-
tures is substantial and will continue to rise [3]. Thus, the
direct, as well as indirect, costs of fractures are expected to
increase correspondingly worldwide [4].
Recent epidemiological studies have suggested that the
incidence of osteoporosis varies among populations, as
the result of the complex interactions of a variety of
genetic, geographic, and ethnic factors [5-7]. Although
family and twin studies have suggested that there is a
strong genetic component which predisposes to oste-
oporosis, environmental factors like nutrition, mechani-
cal load, and lifestyle are also important [8]. The relative
impact of environmental and genetic factors on the pre-
disposition to osteoporosis is still a matter of debate.
Investigation of the role of dietary habits on the develop-
ment and prevention of postmenopausal osteoporosis has
focused primarily on calcium intake and vitamin D reple-
tion. These two factors, albeit important, only account for
the development of osteoporosis in part. Indeed, the inci-
dence of osteoporosis in homogeneous populations corre-
lates inversely with calcium intake [9], and it appears that
the highest total incidence of fractures is experienced by
populations with the highest calcium consumption [10].
Since differences in nutrition between populations can be
striking and are not limited to calcium intake, it is possible
that other macro- and micro-nutrients may contribute to the
different incidence of fractures between populations [11].
Recently, the beneficial effects of various classes of phy-
toestrogens present in nature were reported [12]. Phytoes-
trogens are abundant in plants and have received
increasing attention as dietary components that can affect
several aspects of human health [13]. Phytoestrogens are
non-steroidal plant molecules whose structure differs
from gonadal hormones, yet have estrogen-type bioactiv-
ity [12,14]. The notion that phytoestrogens may affect
osteoporosis favorably has emerged recently [15] and is
supported by the observations that phytoestrogens are
beneficial for manifestations of the postmenopausal state
such as hyperlipidemia [16] and hot flushes [17]. Moreo-
ver, the synthetic phytoestrogen, ipriflavone, exerts posi-
tive effects on the bone mass of postmenopausal women
[18] and experimental animals [19]. This beneficial effect
has also been reported from human feeding trials [20,21].
Soy protein and flaxseed are the most common sources of
phytoestrogens in the Western diet. This study was
designed to elucidate whether long term systemic admin-
istration of an isoflavone-rich diet is capable of preventing
the rapid bone loss occurring after surgical castration in
young female rats and, if it is, to gain insight into the
mechanisms of this effect.
Materials and methods
The study was designed to elucidate whether the ingestion
of an isoflavone-rich diet before ovariectomy can prevent
bone loss following ovariectomy. The experimental rat iso-
flavone diet was a kind gift from King Car Food Industrial
Co., Ltd (Taipei, Taiwan, ROC). Thirty-day-old nulliparous
Wistar rats (Animal Center of National Taiwan University
Hospital) weighing 180 ± 10 g were housed individually
and adapted to a casein-based diet consisting of a nutrition-
ally complete formula [22], including 0.6% calcium, 0.8%
phosphorus, and 45 ng of vitamin D3 per gram dry diet.
Access to food and water was ad libitum. For each rat, food
intake was recorded daily and body weight was recorded
weekly throughout the study. Following 1 week of adapta-
tion, 24 rats were randomly divided into four groups.
Groups A and B, the normal diet groups, were provided a
casein-based diet, consisting of a nutritionally complete
formula, throughout the entire three month study period.
In Group A, a sham operation without ovariectomy was
performed one month after beginning a normal diet (i.e.,
nutritionally complete formula as above), while the rats in
Group B underwent bilateral ovariectomy via a bilateral ret-
roperitoneal approach. The rats of Groups C and D were fed
an isoflavone-rich diet (i.e., isoflavone extract from soy
beans, 25 g/rat/day) for one month, then bilateral ovariec-
tomy was performed. The diet of the rats in Group C was
changed to a normal diet after ovariectomy. The rats in
Group D were continuously fed with an isoflavone-rich
diet for an additional two months (Table 1).
Table 1: Experimental Design (n = 6)
Group Isoflavone-rich diet 1st month Isoflavone-rich diet 2nd & 3rd 
months
Ovariectomy
A---
B--+
C+-+
D+++Journal of Orthopaedic Surgery and Research 2008, 3:12 http://www.josr-online.com/content/3/1/12
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Under general anesthesia with ketamine, ovariectomy was
performed by ligation and excision of the ovaries along
the upper horns. In the sham operation, the ovaries were
exposed as above and gently manipulated, but not
excised. In an unpublished pilot study, we demonstrated
that bone loss occurs three weeks after ovariectomy. In the
early morning after a 12 hour fast, the isoflavones were
administered via a funnel-shaped feeding tube through
the mouth once a day. During the daytime, the animals
were fed Purina Laboratory Chow ad libitum and housed
in a temperature-, humidity-, and light-controlled envi-
ronment. Surgical procedures and experimental protocols
were approved and under the supervision of the Animal
Research Committee of the National Taiwan University.
The rats were sacrificed 60 days after surgery by methofane
injection and exsanguination (i.e., on day 90 of the
study). For all rats, whole blood samples were obtained
with plastic syringes via intracardiac puncture both before
surgery and immediate after death. The blood samples
were put on ice, centrifuged to separate the serum, divided
into aliquots of 500 μl, and deep-frozen at -80°C until
further analysis.
After sacrificing the rats, the long bones of the hindlimb,
including the femur and tibia, and the thoracolumbar
spine, were harvested promptly. The long bones of the
right hindlimb and the whole lumbar vertebrae, were
trimmed of soft tissue and burned; the weight of bone ash
of each bone was then measured for further analysis. A
histological study of cancellous bone was done on the
proximal femur, the proximal tibia of the left limb, and
the last thoracic vertebrae. After necropsy, the last thoracic
vertebrae and long bones were dissected out and fixed
with 4% formaldehyde in phosphate-buffered solution
for 18 hours, followed by decalcification, and then dehy-
drated in alcohol, cleared in xylene, and embedded in par-
affin. Sections, 5 to 7 μm in thickness, were cut and
stained with hematoxylin and eosin. Representative sec-
tions were photographed using light microscopy. The
thickness and interconnections between trabeculae were
recorded. The histological observation of bone tissue was
performed by a MICD image analyzing system (MICD
Software Series, Image Research Inc., Ontario, Canada).
The mean percent of porosity of bone tissue was measured
by dividing the observed area, without bone tissue, by the
whole area.
Biochemical indices of skeletal metabolism, such as alka-
line phosphatase (ALP; procedure no. ALP-10, Sigma Co.,
St. Louis, MO, USA), aspartate aminotransferase, and
alanine aminotransferase (AST/GOT and ALT/GPT; proce-
dure no. 505-OP, Sigma Co.), amylase (AMY; procedure
no. Amylase-10, Sigma Co.), creatinine (CRE; procedure
no. 555-A, Sigma Co.), calcium (CA; procedure no. 587-
100P, Sigma Co.), and inorganic phosphorus (IP; proce-
dure no. 363-3-100P, Sigma Co.) content in the serum
were measured with commercially available assay kits.
Parathyroid hormone (PTH) content in the serum was
also measured with commercially available assay kits
(IMMULITE 2000 Intact PTH, Diagnostic Products Corpo-
ration, Los Angeles, CA, USA).
Statistical Analysis
The data obtained were evaluated by analysis of variance
(ANOVA). Post hoc tests were performed with Bonfer-
roni's test. Statistical significance was considered as a P <
0.05.
Results
After ingestion of an isoflavone-rich diet for one to three
months, the biochemical parameters in serum, including
ALP, amylase, CA, GOT, and IP did not change signifi-
cantly (P > 0.05; Figure 1). At the conclusion of the study,
the measurements of body weight, serum creatinine, GPT,
and PTH attained a higher value as compared with the
preoperative baseline values; however, there were no sta-
tistically significant differences between the groups at the
end of the study period (Figure 1).
After ovariectomy, the bone ash of long bones in the hind-
limbs was significantly lower than that of sham-operated
groups (Figure 2). When compared with the sham-oper-
ated rats fed a normal diet (Group A), the bone mass of
the ovariectomy group (Group B) were 34.9%, 9.7%, and
23.8% lower in the spine, femur, and tibia, respectively.
The bone ash of Group C (an isoflavone-rich diet for one
month followed by ovariectomy and a normal diet) were
32.3%, 11.7%, and 45.9% lower in the spine, femur, and
tibia, respectively; while in Group D (an isoflavone-rich
diet for three months), the bone ash of the femur and tibia
were 59.7% and 44.2% higher than that of sham-operated
normal control rats, respectively (Figure 2).
In the histological study of the last thoracic vertebrae in
sham-operated normal rats, the cancellous bone showed
intervening trabecular bone with connectivity of the
trabecular elements. In rats received ovariectomy fed a
normal diet throughout the entire study period (Group
B), the thinning and disconnection of trabeculae was eas-
ily observed as compared with sham-operated normal
controls and the decrease in bone trabeculae was most sig-
nificant in the proximal tibia (Figure 3). In ovariect-
omized rats provided an isoflavone rich diet for one
month followed by a normal diet (Group C), the same
histological changes occurred as observed in Group B
(Figure 3). When the rats were fed an isoflavone-rich diet
for three months (Group D), the trabeculation in the can-
cellous bone of the proximal femur and tibia was signifi-
cant higher than that of normal controls. The lumbarJournal of Orthopaedic Surgery and Research 2008, 3:12 http://www.josr-online.com/content/3/1/12
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Biochemical parameters of metabolism after ovariectomy with and without an isoflavone-rich soy protein isolate diet Figure 1
Biochemical parameters of metabolism after ovariectomy with and without an isoflavone-rich soy protein iso-
late diet. After ingestion of an isoflavone-rich diet for one to three months, the biochemical parameters in serum, including 
alkaline phosphatase, amylase, calcium, GOT (aspartate aminotransferase), and inorganic phosphorus did not show any signifi-
cant changes (P > 0.05). At the end of the study period, the measurement of body weight, serum creatinine, GPT (alanine ami-
notransferase), and parathyroid hormone attained a higher value as compared with the preoperative baseline values; however, 
there was no statistically significant difference between the groups at the end of the study (P > 0.05). Note: A-Pre: Group A 
rats pre-study; A-Post: Group A rats post-study. B-Pre: Group B rats pre-study; B-Post: Group B rats post-study. C-Pre: 
Group C rats pre-study; C-Post: Group C rats post-study. D-Pre: Group D rats pre-study; D-Post: Group D rats post-study.
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vertebrae appeared to show thickening of trabeculae with
restoration of interconnections (Figure 3).
Mean Percent of Porosity
The ovariectomized rats had a higher, while the rats fed
with isoflavone-rich diet had a lower bone porosity. In
the normal rat (Group A), the mean bone porosity was
76.7%, 79.1%, and 74.3% for the femur, spine, and tibia,
respectively. After ovariectomy (Group B), the mean
bone porosity were significantly higher with the bone
porosity of 89.8%, 89.2%, and 85.7% for the femur,
spine, and tibia, respectively (Figure 4, P < 0.05). The
bone porosity of Group C (an isoflavone-rich diet for
one month followed by ovariectomy and a normal diet)
was still isignificantly higher than that of sham-operated
normal control with the bone porosity of 85.8%, 86.9%,
and 88.2% in the femur, spine, and tibia, respectively.
While in Group D (an isoflavone-rich diet for three
months), the bone porosities of the femur, spine, and
tibia were 59.3%, 66.8%, and 64.0%, respectively, meas-
ured two months after ovariectomy; which were signifi-
cantly lower than that of sham-operated normal control
(Figure 4, P < 0.05).
Weight of long bone ash after ovariectomy with and without an isoflavone-rich diet treatment Figure 2
Weight of long bone ash after ovariectomy with and without an isoflavone-rich diet treatment. After ovariec-
tomy, the bone ash of long bones in the hindlimbs decreased significantly. When compared with the sham-operated rats fed a 
normal diet (Group A), ovariectomy (Group B) decreased the bone mass 34.9%, 9.7%, and 23.8% in the spine, femur, and tibia, 
respectively. Pre-ovariectomy ingestion of an isoflavone-rich diet for one month followed by ovariectomy and a normal diet 
(Group C) decreased the bone ash, 32.3%, 11.7%, and 45.9% in the spine, femur, and tibia, respectively, while ingestion of an 
isoflavone-rich diet for three months (Group D), increased the bone ash of the femur and tibia 59.7% and 44.2%, respectively, 
measured two months after ovariectomy. Note: OVX (-)-ND (3M): Group A, sham-operated rats with a normal diet for three 
months. OVX (+)-ND (3M): Group B, ovariectomized rats with a normal diet for three months. OVX (+)-IRD (1M): Group C, 
ovariectomized rats pretreated with an isoflavone-rich diet for one month followed by a normal diet for two months after ova-
riectomy. OVX (+)-IRD (3M): Group D, ovariectomized rats pretreated with an isoflavone-rich diet for one month followed 
by an isoflavone-rich diet for an additional two months after ovariectomy. *, P < 0.05; **, P < 0.005 when compared with the 
non-ovariectomy group [OVX (-)-ND (3M)].
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Discussion
Osteoporosis is diagnosed by its relatively very low bone
mineral density (BMD). Moreover, many women who are
osteopenic eventually develop osteoporotic fractures [23].
The adult ovariectomized rat is a convenient and reliable
experimental model for the evaluation of agents intended
to prevent and/or treat postmenopausal osteoporosis.
Like humans, rats have cancellous bone that undergoes
remodeling once longitudinal growth has essentially
ceased [24]. In adult rats, ovariectomy is followed by an
increase in bone turnover associated with bone loss and a
permanent deficit of bone mass at several skeletal sites,
including the vertebral bodies, the proximal femur, and
the metaphyses of long bones, such as the distal femur
and proximal tibia [24]. In the current study, the decrease
in bone mass after ovariectomy was observed in the
Histomorphological study of bone trabeculae after ovariectomy and treatment with and without an isoflavone-rich diet Figure 3
Histomorphological study of bone trabeculae after ovariectomy and treatment with and without an isofla-
vone-rich diet. In the histomorphological study of sham-operated normal rats, the cancellous bone showed intervening 
trabecular bone with connectivity of the trabecular elements. In rats fed a normal diet throughout the entire study period 
[(OVX (+)-ND (3M)], there was significant thinning and disconnection of trabeculae after ovariectomy. Rats treated with an 
isoflavone-rich diet for one month followed by a normal diet after ovariectomy [(OVX (+)-IRD (1M)]. When the rats were fed 
an isoflavone-rich diet for three months [OVX (+)-SD (3M)], the trabeculation in the cancellous bone of the proximal femur 
and tibia was significantly higher than that of normal controls. The lumbar vertebrae showed thickening of trabeculae with res-
toration of interconnections. F: proximal femur; Sp: thoracic spine; T: proximal tibia. OVX (-)-ND (3M): Group A, sham-oper-
ated rats with a normal diet for three months. OVX (+)-ND (3M): Group B, ovariectomized rats with a normal diet for three 
months. OVX (+)-SD (1M): Group C, ovariectomized rats pretreated with an isoflavone-rich diet for one month followed by a 
normal diet for two months after ovariectomy. OVX (+)-SD (3M): Group D, ovariectomized rats pretreated with an isofla-
vone-rich diet for one month followed by an isoflavone-rich diet for an additional two months after ovariectomy.Journal of Orthopaedic Surgery and Research 2008, 3:12 http://www.josr-online.com/content/3/1/12
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femur, tibia, and spine, but it was more evident in the
metaphysis of the long bones (Figures 2 and 4).
After treatment with an isoflavone-rich diet for three
months, most of the biochemical parameters in serum did
not show any significant changes. Only the serum titers of
CRE, GPT, and PTH were higher than that of the preoper-
ative baseline values, but there were no statistically signif-
icant differences between the groups at the end of the
study (Figure 1). This observation can be partially
explained by the younger group of premenopausal rats
with higher endogenous estrogen and active physiologic
bone formation at this age [25] or possibly there was no
obvious detrimental physiological effect of an isoflavone-
rich diet on this particular animal model.
When compared with the sham-operated rats fed a nor-
mal diet (Group A), the bone mass of rats with a normal
diet after ovariectomy (Group B) decreased significantly.
Pre-ovariectomy ingestion of an isoflavone-rich diet for
one month did not prevent rats from bone loss (Group
C). As noted in this study, the bone ashes analysis
revealed a greater than 40% reduction in whole tibial
bone mass, greater than a 30% reduction in whole spine
bone mass, and greater than a 10% reduction in whole
femur bone mass two months following ovariectomy
Mean bone porosity after ovariectomy and treatment with and without isoflavone-rich diet Figure 4
Mean bone porosity after ovariectomy and treatment with and without isoflavone-rich diet. In the normal rats 
(Group A), the mean bone porosity was 76.7%, 79.1%, and 74.3% for the femur, spine, and tibia, respectively. After ovariec-
tomy (Group B), the mean bone porosities significantly increased to 89.8%, 89.2%, and 85.7% for the femur, spine, and tibia, 
respectively (P < 0.05). The bone porosities of group C (an isoflavone-rich diet for one month followed by ovariectomy and a 
normal diet) significantly increased to 85.8%, 86.9%, and 88.2% in the femur, spine, and tibia, repectively, while in Group D (an 
isoflavone-rich diet for three months), the bone porosities of the femur, spine, and tibia decreased to 59.3%, 66.8%, and 64.0%, 
respectively, two months after ovariectomy (P < 0.05). Ovariectomy increases, while an isoflavone-rich diet decreases bone 
porosity.
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(Figure 2). Following ovariectomy, the microarchitectural
alterations in cancellous bone were similar to those
observed in postmenopausal and age-dependent oste-
oporosis, which produced architectural discontinuities of
cancellous bone (Figure 3). The lack of an effect of pre-
treatment with an isoflavone-rich diet in ovariectomized
rats is striking, in contrast to its effects on the bone of the
ovariectomized animals fed an isoflavone-rich diet for
three months. An explanation of this lack of effect is not
apparent. Reduction of bone mass in the ovariectomized
rats pretreated with an isoflavone rich-diet suggests that
premenopausal isoflavone supplementation cannot pre-
vent bone loss and osteoporosis following the meno-
pause. Further, in this rat ovariectomy model, the
different degree of bone loss reflects the fact that the early
postovariectomy period is characterized primarily by loss
of bone mass in the long bones such as the tibia and
femur, rather than in the spine.
In this study, the rats were young adults and had not yet
achieved the slowest phase of growth. We found that
although prolonged isoflavone-rich diet intake has a pos-
itive effect on the bone mass, the cessation of an isofla-
vone-rich diet intake does not guarantee that the bone-
sparing effect will persist. This raises the question whether
the presence of a well-formed and active growth plate may
have affected the action of an isoflavone-rich diet on
bone. This fact can be partially explained by the use of
growing animals, as the remodeling of the primary spon-
giosa is also suppressed and the increase in bone area is
not only due to a stimulation of growth but also may be
due to the failure to remodel the primary spongiosa. Stud-
ies in older rats, or ideally in another experimental model
that has a true Haversian system and with remodeling can-
cellous bone, would help to answer this question.
The bone mass of the rats with ingestion of an isoflavone-
rich soy protein isolate for three months still higher than
that of the sham-operated normal control even at two
months after ovariectomy. The treatment of rats with an
isoflavone-rich diet for three months resulted in an
approximately 40–60 % increase of bone mass in the long
bones even when measured two months after ovariec-
tomy (Figure 2). These findings are consistent with the
recent report of Arjmandi BH et al. (1996) that dietary
intake of soybean products prevents bone loss after ova-
riectomy [26]. In a human study, Mei et al. demonstrated
that a habitually high intake of dietary isoflavone is asso-
ciated with a higher bone mineral density value in both
the spine and hip regions, while no association existed
between dietary phytoestrogen intake and bone mineral
density value in premenopausal women with high endog-
enous estrogen [25]. In this study, because there were no
bone ash and histology or histomorphometry measure-
ment on animals after one month feeding isoflavones, we
can not concluded that habitual ingestion of an insofla-
vone-rich diet during the premenopause had a protective
effect against bone loss after ovariectomy. The bone-spar-
ing action did observed in the treated group with long-
term ingestion of an isoflavone-rich diet. The bone-spar-
ing action of isoflavone supplementation primarily effect
the metaphyseal portion of the proximal tibia and the ver-
tebrae of spine. Customarily, high isoflavone intake may
also help to reverse the state of secondary hyperparathy-
roidism associated with estrogen withdrawal and hence
lower the rate of bone turnover in postmenopausal
women [25]. In our study, the rats fed with an isoflavone-
rich diet were protected completely from bone loss after
castration, which is similar to that reported by Arjmandi
et al. [26]. Whether the discrepancy between our study
and that of Arjmandi et al. [26] is that bone mass was
increased after intake of an isoflavone-rich diet for three
months need to be further validated in the future study.
The possibility that the effect of 25 mg/rat/day of isofla-
vones on bony tissues of the ovariectopmized rats is via a
non-estrogenic mechanism is supported by the presented
noninvasive and histological results. In fact, the higher
number of bone tracbeculae measured in the ovariect-
omized- rats fed an isoflavone-rich soy protein isolate is
indicative of a preventive effect of isoflavones on bone
loss (Figure 3). This response of bone is different from
that expected following administration of estradiol, since
most investigators have reported that the rate of bone for-
mation of ovariectopmized rats is suppressed, rather than
stimulated, by exogenous estradiol [27-29]. Whether the
preventive effect on bone loss of an isoflavone-rich diet
on bone formation is mediated by a preferential interac-
tion of this ligand with the estrogen receptor β, or by inter-
action with selective estrogen receptor modulators such as
the raloxifene-response element, or by non-receptor-
mediated direct effects on specific intracellular enzymes,
warrants future investigation.
In summary, there are limitations in this study. The first
one is the animal age, which is much younger than that
usually used for the postmenopusal model; the second
one is that the bone histological study used in this study
is mainly a 2-dimensional approach with inherent model-
based assumption, i.e., indirect measurement of micro-
structure; and the housing of rats individually may be also
a stressor that confounds interpretation [30]. However,
the premenopausal ingestion of isoflavone does not pre-
vent the development of post-ovariectomized bone loss,
while the habitual ingestion of an isoflavone-rich diet
does increase the bone mineral contents in the long bones
of ovariectomized rats. The mechanism by which an iso-
flavone-rich soy protein isolate acts on bone resorption is
still unknown and should be the subject of additional
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